Bajaj Healthcare Gets CDSCO Approval for Suvorexant Tablets Clinical Trial
Bajaj Healthcare Limited (BHL) announced today, December 31, 2025, that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to conduct a Clinical Trial and Bioequival...
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is Bajaj Healthcare Limited in the news today?
Bajaj Healthcare Limited (BAJAJHCARE) is in the news due to the approval from cdsco for conducting clinical trials is a positive development for the company, indicating progress in product development.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Bajaj Healthcare Gets CDSCO Approval for Suvorexant Tablets Clinical Trial
December 31, 2025, 01:48 PM
Top Queries to Ask About Bajaj Healthcare Limited
More Details on This News
Bajaj Healthcare Limited (BHL) announced today, December 31, 2025, that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to conduct a Clinical Trial and Bioequivalence Study for its Suvorexant Tablets.
This approval follows a recommendation received from the Subject Expert Committee (SEC) (Neurology & Psychiatry) of CDSCO on October 04, 2025, for conducting Phase III clinical trials for the same product.
The company stated that this approval enables them to proceed with the necessary clinical trials and bioequivalence studies for Suvorexant Tablets. Further details regarding the approval are enclosed as Annexure-I, as per SEBI Listing Regulations.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap
